Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/37229
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | White, D. | - |
dc.contributor.author | Saunders, V. | - |
dc.contributor.author | Quinn, S. | - |
dc.contributor.author | Manley, P. | - |
dc.contributor.author | Hughes, T. | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | Blood, 2007; 109(8):3609-3610 | - |
dc.identifier.issn | 0006-4971 | - |
dc.identifier.issn | 0006-4971 | - |
dc.identifier.uri | http://hdl.handle.net/2440/37229 | - |
dc.language.iso | en | - |
dc.publisher | Amer Soc Hematology | - |
dc.source.uri | http://dx.doi.org/10.1182/blood-2006-11-058032 | - |
dc.subject | Cell Line | - |
dc.subject | Animals | - |
dc.subject | Humans | - |
dc.subject | Mice | - |
dc.subject | Leukemia | - |
dc.subject | Benzamides | - |
dc.subject | Piperazines | - |
dc.subject | Pyrimidines | - |
dc.subject | Phosphotyrosine | - |
dc.subject | Fusion Proteins, bcr-abl | - |
dc.subject | Antineoplastic Agents | - |
dc.subject | Drug Therapy, Combination | - |
dc.subject | Xenograft Model Antitumor Assays | - |
dc.subject | Apoptosis | - |
dc.subject | Drug Synergism | - |
dc.subject | Models, Biological | - |
dc.subject | Male | - |
dc.subject | Imatinib Mesylate | - |
dc.title | Imatinib increases the intracellular concentration of nilotinib which may explain the observed synergy between these drugs | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1182/blood-2006-11-058032 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | White, D. [0000-0003-4844-333X] | - |
dc.identifier.orcid | Hughes, T. [0000-0002-0910-3730] [0000-0002-7990-4509] | - |
Appears in Collections: | Aurora harvest Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.